Fielmann Aktiengesellschaft (FLMNF)
USD 46.75
(-1.23%)
USD 46.75
(-1.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 533.22 Million EUR | -3.23% |
| 2022 | 550.99 Million USD | 40.37% |
| 2021 | 392.52 Million USD | -15.51% |
| 2020 | 464.57 Million USD | 70.57% |
| 2019 | 272.37 Million USD | 297.75% |
| 2018 | -137.73 Million EUR | 19.25% |
| 2017 | -170.57 Million EUR | -51.32% |
| 2016 | -112.72 Million EUR | -19.03% |
| 2015 | -94.69 Million EUR | 24.94% |
| 2014 | -126.16 Million EUR | 6.9% |
| 2013 | -135.5 Million EUR | 51.04% |
| 2012 | -276.76 Million EUR | -128.8% |
| 2011 | -120.96 Million EUR | 5.51% |
| 2010 | -128.02 Million EUR | -92.08% |
| 2009 | -66.65 Million EUR | 9.26% |
| 2008 | -73.45 Million EUR | 31.05% |
| 2007 | -106.52 Million EUR | -2.38% |
| 2006 | -104.04 Million EUR | -27.09% |
| 2005 | -81.87 Million EUR | -106.23% |
| 2004 | -39.69 Million EUR | 29.84% |
| 2003 | -56.58 Million EUR | -34.62% |
| 2002 | -42.02 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 88.3 Million EUR | -84.65% |
| 2024 Q2 | 180.88 Million EUR | 121.03% |
| 2023 Q4 | 533.22 Million EUR | 197.33% |
| 2023 FY | 533.22 Million EUR | -3.23% |
| 2023 Q3 | 179.33 Million EUR | -61.32% |
| 2023 Q1 | 459.26 Million USD | -16.65% |
| 2023 Q2 | 463.57 Million USD | 0.94% |
| 2022 Q3 | 428.8 Million USD | 42.45% |
| 2022 Q1 | 289.56 Million EUR | 2.19% |
| 2022 Q2 | 301.01 Million EUR | 3.95% |
| 2022 Q4 | 550.99 Million USD | 28.49% |
| 2022 FY | 550.99 Million USD | 40.37% |
| 2021 Q1 | 268.53 Million EUR | -16.6% |
| 2021 FY | 392.52 Million USD | -15.51% |
| 2021 Q4 | 283.36 Million EUR | 7.87% |
| 2021 Q2 | 263.79 Million EUR | -1.77% |
| 2021 Q3 | 262.69 Million EUR | -0.42% |
| 2020 Q1 | 207.51 Million EUR | -14.27% |
| 2020 Q2 | 222.65 Million EUR | 7.3% |
| 2020 Q3 | 131.79 Million EUR | -40.81% |
| 2020 Q4 | 322 Million EUR | 144.32% |
| 2020 FY | 464.57 Million USD | 70.57% |
| 2019 FY | 272.37 Million USD | 297.75% |
| 2019 Q2 | 161.79 Million EUR | -30.76% |
| 2019 Q3 | 209.47 Million EUR | 29.46% |
| 2019 Q1 | 233.67 Million EUR | 269.65% |
| 2019 Q4 | 242.06 Million EUR | 15.56% |
| 2018 Q3 | -156.37 Million EUR | 46.69% |
| 2018 Q4 | -137.73 Million EUR | 11.92% |
| 2018 FY | -137.73 Million EUR | 19.25% |
| 2018 Q1 | -214.78 Million EUR | -25.92% |
| 2018 Q2 | -293.3 Million EUR | -36.56% |
| 2017 Q1 | -171.96 Million EUR | -52.56% |
| 2017 Q4 | -170.57 Million EUR | -9.17% |
| 2017 Q3 | -156.24 Million EUR | -79.7% |
| 2017 FY | -170.57 Million EUR | -51.32% |
| 2017 Q2 | -86.94 Million EUR | 49.44% |
| 2016 Q2 | -164.13 Million EUR | -66.89% |
| 2016 FY | -112.72 Million EUR | -19.03% |
| 2016 Q3 | -155.18 Million EUR | 5.45% |
| 2016 Q4 | -112.72 Million EUR | 27.36% |
| 2016 Q1 | -98.34 Million EUR | -3.85% |
| 2015 FY | -94.69 Million EUR | 24.94% |
| 2015 Q2 | -195.16 Million EUR | -28.23% |
| 2015 Q3 | -103.23 Million EUR | 47.1% |
| 2015 Q4 | -94.69 Million EUR | 8.27% |
| 2015 Q1 | -152.19 Million EUR | -20.64% |
| 2014 Q1 | -195.32 Million EUR | -44.14% |
| 2014 FY | -126.16 Million EUR | 6.9% |
| 2014 Q3 | -186.64 Million EUR | 21.12% |
| 2014 Q2 | -236.63 Million EUR | -21.15% |
| 2014 Q4 | -126.16 Million EUR | 32.41% |
| 2013 Q1 | -193.3 Million EUR | 30.16% |
| 2013 FY | -135.5 Million EUR | 51.04% |
| 2013 Q3 | -162.99 Million EUR | 32.41% |
| 2013 Q2 | -241.15 Million EUR | -24.75% |
| 2013 Q4 | -135.5 Million EUR | 16.86% |
| 2012 FY | -276.76 Million EUR | -128.8% |
| 2012 Q3 | -149.43 Million EUR | 36.15% |
| 2012 Q4 | -276.76 Million EUR | -85.21% |
| 2012 Q2 | -234.04 Million EUR | -36.48% |
| 2012 Q1 | -171.48 Million EUR | -41.76% |
| 2011 Q3 | -80.8 Million EUR | 19.27% |
| 2011 Q4 | -120.96 Million EUR | -49.7% |
| 2011 FY | -120.96 Million EUR | 5.51% |
| 2011 Q1 | -92.3 Million EUR | 27.9% |
| 2011 Q2 | -100.09 Million EUR | -8.44% |
| 2010 Q2 | -111.01 Million EUR | -38.33% |
| 2010 Q4 | -128.02 Million EUR | -53.46% |
| 2010 Q1 | -80.24 Million EUR | -20.4% |
| 2010 Q3 | -83.42 Million EUR | 24.85% |
| 2010 FY | -128.02 Million EUR | -92.08% |
| 2009 FY | -66.65 Million EUR | 9.26% |
| 2009 Q4 | -66.65 Million EUR | 0.0% |
| 2008 FY | -73.45 Million EUR | 31.05% |
| 2007 FY | -106.52 Million EUR | -2.38% |
| 2006 FY | -104.04 Million EUR | -27.09% |
| 2005 FY | -81.87 Million EUR | -106.23% |
| 2004 FY | -39.69 Million EUR | 29.84% |
| 2003 FY | -56.58 Million EUR | -34.62% |
| 2002 FY | -42.02 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -111073.381% |
| Ansell Limited | -54.99 Million USD | 1069.55% |
| Ansell Limited | -55.1 Million USD | 1067.735% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 1561.156% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 507437.634% |
| Psykey, Inc. | 634.59 Thousand USD | -83925.824% |
| ConvaTec Group Plc | 1.2 Billion USD | 55.587% |
| ConvaTec Group Plc | 1.2 Billion USD | 55.65% |
| Encision Inc. | 1.29 Million USD | -41212.845% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -22996.031% |
| Innovative MedTech Inc. | 1.76 Million USD | -30115.398% |
| LifePoint, Inc. | -3.26 Million USD | 16436.353% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | -10772.802% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | -24563.367% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 1231445.834% |
| Reflect Scientific, Inc. | -1.03 Million USD | 51603.757% |
| SmileDirectClub, Inc. | 778.67 Million USD | 31.522% |
| Sector 10, Inc. | 163 Thousand USD | -327030.061% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 227.701% |
| SheerVision, Inc. | 57.34 Thousand USD | -929684.303% |
| United Health Products, Inc. | 660.56 Thousand USD | -80621.62% |
| Vasamed, Inc. | 22.12 Thousand USD | -2410269.768% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | -20165.208% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -68945.254% |